Inventor · disambiguated record
Neil Spector
Also filed as: SPECTOR NEIL · SPECTOR NEIL L · SPECTOR NEIL LEE
11 granted patents·12 pending applications·182 citations·filing 1999–2022
89Inventor score
Top patents by PatentIndex Score
23 records- 0193US7829297B2Treatment of cancers expressing p95 ErbB2GLAXOSMITHKLINE LLC·Filed 2009·Granted Nov 9, 2010·16 cites·8 claims
- 0289US7141576B2Cancer treatment methodSMITHKLINE BEECHAM CORK LTD·Filed 2002·Granted Nov 28, 2006·68 cites·2 claims
- 0387US11207409B2X-RAY psoralen activated cancer therapy (X-PACT) with associated treatmentsIMMUNOLIGHT LLC·Filed 2018·Granted Dec 28, 2021·3 cites·32 claims
- 0485US9439897B2Use of psoralen derivatives and combination therapy for treatment of cell proliferation disordersIMMUNOLIGHT LLC·Filed 2015·Granted Sep 13, 2016·6 cites·29 claims
- 0583US6277844B1Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosisFiled 1999·Granted Aug 21, 2001·82 cites·27 claims
- 0681US11305131B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2019·Granted Apr 19, 2022·1 cites·37 claims
- 0774US10441810B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2017·Granted Oct 15, 2019·3 cites·41 claims
- 0868US8444988B2Cancer treatment methodLACKEY KAREN ELIZABETH·Filed 2011·Granted May 21, 2013·2 cites·4 claims
- 0967US11992697B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2022·Granted May 28, 2024·0 cites·35 claims
- 1064US7794960B2Predictive biomarkers in cancer therapyGLAXOSMITHKLINE LLC·Filed 2005·Granted Sep 14, 2010·1 cites·4 claims
- 1162US2006204966A1Treatment of cancers expressing p95 erbb2SPECTOR NEIL L·Filed 2004·Application pending·0 cites
- 1257US2015190397A1Treatment of Cancers Expressing p95 ErbB2GLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 1357US2011020335A1Treatment of Cancers Expressing p95 ErbB2SPECTOR NEIL LEE·Filed 2010·Application pending·0 cites
- 1450US2007148261A1Cancer treatment methodLACKEY KAREN E·Filed 2006·Application pending·0 cites
- 1547US2007059785A1Biomarkers in cancerSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 1646US2015366868A1Cancer treatment methodLACKEY KAREN ELIZABETH·Filed 2015·Application pending·0 cites
- 1744US2011312982A1Cancer Treatment MethodLACKEY KAREN ELIZABETH·Filed 2011·Application pending·0 cites
- 1844US2016331731A1Use of psoralen derivatives and combination therapy for treatment of cell proliferation disordersIMMUNOLIGHT LLC·Filed 2016·Application pending·0 cites
- 1942US9937178B2Methods of identifying and using MDM2 inhibitorsUNIV DUKE·Filed 2012·Granted Apr 10, 2018·0 cites·14 claims
- 2042US2006094068A1Predictive markers in cancer therapyBACUS SARAH S·Filed 2003·Application pending·0 cites
- 2141US2010249160A1Cancer Treatment MethodLACKEY KAREN ELIZABETH·Filed 2010·Application pending·0 cites
- 2240US2005176740A1Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitorFiled 2003·Application pending·0 cites
- 2330US2010063074A1Cancer Treatment MethodBERGER MARK S·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil Spector files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →